Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Orexo buys fellow Swedish company Biolipox for SEK803mm

Executive Summary

Drug delivery company Orexo AB is issuing 8.56mm of its shares to acquire Biolipox AB (anti-inflammatory drug candidates) in a deal worth SEK803mm ($125mm) based on Orexo's ten-day average prior to deal announcement.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock
    • Acquisition of Private Biotech

Related Companies